Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Half-year summaryof NATUREX's liquidity contract, June 2014



Pursuant to the liquidity contract granted to EXANE BNP PARIBAS regarding NATUREX shares, the following elements were in the liquidity account as of June 30, 2014, negotiation date: 


  • 4,853 NATUREX shares

  • 850 Subscription rights

  • 523,937.00 euros 

It is reminded that the following assets appeared on the liquidity account as of December 31, 2013, settlement date:


  • 8,642 NATUREX shares

  • 269,721.00 euros 





If you would like to receive financial information about Naturex by e-mail, go to: www.naturex.com







Naturex has been listed on Euronext Paris, Compartment B (MidCaps), since October 1996.

 








NATUREX

Total number of shares comprising the share capital: 9,182,307

ISIN FR0000054694



Naturex is a component of the CAC Small and Gaïa indexes.

Naturex is eligible for "long only" Deferred Settlement Service (SRD).

Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.


SYMBOL: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY






About NATUREX 

 

NATUREX is the global leader in specialty plant-based natural ingredients. The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets specialty plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.

 

NATUREX is the global leader in specialty plant-based natural ingredients. The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets specialty plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.



 

Contacts

 













Thierry Lambert


Chair and Chief Executive Officer

Tel.: +33 (0)4 90 23 96 89 



Thierry-Bertrand Lambert


Chief Financial Officer

Tel.: +33 (0)4 90 23 96 89 



Carole Alexandre


Investor Relations

Tel.: +33 (0)4 90 23 78 28 



Anne Catherine Bonjour


Actus Finance Press Relations

Tel.: +33 (0)1 53 67 36 93




Information réglementée
Rachat d'actions / contrat de liquidité :

- Information relative au contrat de liquidité

Communiqué intégral et original au format PDF :


http://www.actusnews.com/documents_communiques/ACTUS-0-36582-Half-year-summary-of-NATUREX_s-liquidity-contract_June-2014.pdf

© Copyright Actusnews Wire

Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free



Quelle: Actusnews

Like: 0
Share

Comments